Market Access Transformation, a Genesis Research company
Dr. Kuldeep Kumar Singh has had a diverse range of work experience in the field of market access and healthcare consulting. Dr. Kuldeep most recently served as the Global Head of Market Access Operations at Market Access Transformation, where they revolutionized the way healthcare stakeholders exchange advice and developed market access strategies for oncology and non-oncology indications. Prior to that, Dr. Singh worked at PRMA Consulting Ltd as a consultant, managing projects and offering consultancy on market access strategy for various pharmaceutical companies. Dr. Kuldeep also gained experience in market access and pricing during their time at Novartis, where they collaborated with different teams to support successful market access to products. Dr. Singh's earlier experience includes working as a consultant at the World Health Organization, where they collaborated with local administration and agencies for successful immunization programs, and as a general physician and hospital manager at NIMS University, where they played a key role in the foundation and management of a medical college and hospital.
Dr. Kuldeep Kumar Singh has a comprehensive education history with a focus on health economics, public health, and medicine. Dr. Kuldeep began their educational journey in 1997 at King George's Medical University where they pursued a Bachelor of Medicine, Bachelor of Surgery (MBBS) degree, which they completed in 2003. Following this, they further expanded their knowledge and qualifications in the field of healthcare by obtaining a Postgraduate Diploma in Health economics, Health care finance, and Health policy from the Indian Institutes of Public Health (IIPHs) in 2009.
In 2009-2010, Dr. Singh pursued multiple Master of International Health (MIH) degrees in different specializations. At Humboldt-Universität zu Berlin, they focused on health economics, vaccinology, and public health. Simultaneously, they enrolled in the Karolinska Institutet to study International Public Health and International Health. Additionally, they pursued a MIH degree at the University College London (UCL), specializing in Maternal and Child Health.
Dr. Singh expanded their academic credentials by completing a Master of Business Administration (MBA) from the prestigious London Business School from 2014 to 2016. Though specific field of study for the MBA is not mentioned, it adds to their diverse educational background and could potentially contribute to their understanding of healthcare management and administration.
Overall, Dr. Kuldeep Kumar Singh's education history encompasses a wide range of disciplines in medicine, public health, health economics, and business administration.
This person is not in any offices
Market Access Transformation, a Genesis Research company
**May 2022 Genesis Research acquired Marketing Access Transformation** Founded in 2016, Market Access Transformation (MAT) specializes in developing agile technology platforms that enable the healthcare community to exchange insights that asses the real-world potential of their pharmaceutical products. With close to 65 employees that span the US, UK and India, MAT is seen as a revolutionary company in the global pharmaceutical research space. Our primary platform, Rapid Payer Responses™ (RPR), enables pharmaceutical manufacturers to conduct critical market access research throughout the product and treatment development process. Through our global, vetted payer network, it is possible to gather more accurate, robust feedback and insights by probing further and asking deeper questions. you always have the exact answers you need in a fraction of the time and cost of a traditional payer research project. Our life science experts help facilitate this process, monitoring the responses in real time as they come in for quality and detail. Since the launch of Rapid Payer Response™ (RPR) in July 2016, we have partnered with over 50 of the leading pharmaceutical manufacturers, expanded our payer network to more than 45 countries and have achieved an impressive 93% license renewal rate as we continue to disrupt the older and outdated models for payer research. Were are diverse minded, global company with offices in the US (NJ, NY & CA), UK and India. If you are interested in joining our amazing MAT team, check our openings at https://www.marketaccesstransformation.com/careers